| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |